Injection of bone marrow MSCs into diabetic mice can increase insulin levels and downregulate hyperglycemia; the exosomes derived from human umbilical cord stem cells (hUCMSCs) can enhance insulin sensitivity (52). Here, INS is linked to Hyperglycemia.